Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 15, 2007

Pfizer Animal Health Gains Access to Crucell’s PER.C6

  • Crucell and Pfizer Animal Health signed  a research license agreement for PER.C6®. The deal allows Pfizer Animal Health to use the cell technology in the production of a undisclosed veterinary vaccine.

    Pfizer Animal Health has an option to convert the research license into a commercial agreement.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »